Cytek Biosciences Inc

CTKB.US
Healthcare · Medical Devices
4.46
+0.05 (+1.13%)
USD · NASDAQ

Company Information

Company Name
Cytek Biosciences Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US23285D1090
CIK: 0001831915
CUSIP: 23285D109
Currency: USD
Full Time Employees: 678
Phone: 877 922 9835
Fiscal Year End: December
IPO Date: Jul 23, 2021
Description:

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Address:

47215 Lakeview Blvd, Fremont, CA, United States, 94538-6407

People

Directors & Officers

Name Title Year Born
Dr. Wenbin Jiang Ph.D. President, CEO & Chairman of the Board 1964
Mr. William D. McCombe Chief Financial Officer 1958
Dr. Ming Yan Ph.D. CTO & Director 1963
Mr. Paul D. Goodson Head of Investor Relations NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 02, 2025 William D Mccombe N/A Purchase 35.00K $2.78 $97.30K
Jun 02, 2025 William D Mccombe N/A Purchase 35.00K $2.78 $97.30K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 17.01M Mar 31, 2026 13.17% $0.00 -0.97%
Vanguard Group Inc 7.48M Dec 31, 2025 5.79% $0.00 7.82%
Topline Capital Management LLC 7.06M Mar 31, 2026 5.47% $5.10 -5.08%
Hillhouse Capital Advisors, Ltd. 6.66M Mar 31, 2026 5.15% $1.74 0.00%
Millennium Management LLC 6.29M Mar 31, 2026 4.87% $0.01 32.39%
Boston Partners Global Investors, Inc 5.80M Mar 31, 2026 4.49% $0.03 15.86%
Vanguard Capital Management, LLC 4.76M Mar 31, 2026 3.69% $0.00 0.00%
State Street Corp 4.12M Mar 31, 2026 3.19% $0.00 -0.56%
Geode Capital Management, LLC 2.83M Mar 31, 2026 2.19% $0.00 1.55%
Dimensional Fund Advisors, Inc. 2.66M Mar 31, 2026 2.06% $0.00 0.62%
The Goldman Sachs Group Inc 2.34M Mar 31, 2026 1.82% $0.00 31.00%
Vanguard Portfolio Management, LLC 2.31M Mar 31, 2026 1.79% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 1.72M Mar 31, 2026 1.33% $0.00 1.05%
Royce & Associates, LP 1.64M Mar 31, 2026 1.27% $0.07 -2.97%
Brown Capital Management, LLC 1.48M Mar 31, 2026 1.15% $0.92 -28.58%
Charles Schwab Investment Management Inc 1.10M Mar 31, 2026 0.86% $0.00 0.92%
Bank of America Corp 1.01M Mar 31, 2026 0.78% $0.00 17.86%
Northern Trust Corp 1.01M Mar 31, 2026 0.78% $0.00 4.97%
AQR Capital Management LLC 912.34K Mar 31, 2026 0.71% $0.00 22.72%
Simcoe Capital LLC 882.11K Mar 31, 2026 0.68% $3.54 195.55%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 3.53M 2.73% ▲ 3.36% Jun 30, 2026
2 iShares Russell 2000 ETF 3.18M 2.47% ▲ 0.60% Jun 30, 2026
3 Column Small Cap Select 2.61M 2.02% ▲ 29.19% Jun 30, 2026
4 Royce Micro-Cap Trust 1.32M 1.02% ▲ 32.13% Jun 30, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 1.30M 1.01% ▲ 4.79% Jun 30, 2026
6 Fidelity Small Cap Index 1.16M 0.90% ▲ 0.84% Apr 30, 2026
7 iShares Russell 2000 Value ETF 1.10M 0.85% ▼ 0.69% Jun 30, 2026
8 iShares Biotechnology ETF 841.98K 0.65% ▲ 1.05% Jun 30, 2026
9 Russell 2000 Index Non-Lendable Fund 809.97K 0.63% ▲ 5.14% Jun 30, 2026
10 Russell 2000 Equity Index Fund B 809.97K 0.63% ▲ 5.14% Jun 30, 2026

Financial Highlights

Market Cap: $569.52M
EBITDA: $-36.30M
Book Value: $2.54
Earnings/Share: $-0.57
Profit Margin: -36.25%
Operating Margin: -41.83%
ROA (TTM): -5.89%
ROE (TTM): -20.93%
Revenue (TTM): $204.17M
Revenue/Share (TTM): $1.60
Earnings Growth (YOY): 73.50%
Revenue Growth (YOY): 6.50%

Valuation Metrics

Enterprise Value: $341.23M
Trailing P/E: 0.00
Forward P/E: 370.37

Shares Statistics

Shares Outstanding: 129.14M
Shares Float: 96.58M
% Insiders: 841.50%
% Institutions: 6,625.20%
Short % Float: 4.94%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$201.49M
Cost of Goods Sold
adjust
$-97.03M
Gross Profit
subtotal
$104.46M
SG&A
adjust
$-58.94M
R&D
adjust
$-36.47M
Other Operating Expense
adjust
$-49.44M
Operating Income
subtotal
$-40.38M
Other / Non-Operating Items
adjust
$-26.16M
Net Income
subtotal
$-66.54M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CTKB.US!